Endometrial Cancer Collection

Endometrial Cancer Collection

Editors of the AACR journals reviewed recently published content to identify hot topics across the entire portfolio. This publication focuses on endometrial cancer and highlights articles based on a number of key metrics, such as usage and citations. We hope that you enjoy this complimentary cross-journal collection.

• Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86)
  Neesha C. Dhani et al. Clinical Cancer Research June 2020.
• Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors
  Junji Tsurutani et al. Cancer Discovery May 2020.
• Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing
  Martee L. Hensley et al. Clinical Cancer Research July 2020.
• Prognostic Integrated Image-Based Immune And Molecular Profiling In Early-Stage Endometrial Cancer
  Nanda Horeweg et al. Cancer Immunology Research OnlineFirst September 2020.
• Intercepting Endometrial Cancer: Opportunities to Expand Access Using New Technology
  Christopher C. DeStephano et al. Cancer Prevention Research July 2020.
• PROgesterone Therapy for Endometrial Cancer protection in obese women (PROTEC) trial: a feasibility study
  Abigail E. Derbyshire et al. Cancer Prevention Research OnlineFirst September 2020.
• Adiposity and endometrial cancer risk in postmenopausal women: a sequential causal mediation analysis
  S. Ghazaleh Dashti et al. Cancer Epidemiology, Biomarkers and Prevention OnlineFirst October 2020.
• Dietary Intake of Acrylamide and Risk of Breast, Endometrial, and Ovarian Cancers: A Systematic Review and Dose–Response Meta-analysis
  Giorgia Adani et al. Cancer Epidemiology, Biomarkers and Prevention June 2020.
• SIX1 Regulates Aberrant Endometrial Epithelial Cell Differentiation and Cancer Latency Following Developmental Estrogenic Chemical Exposure
  Alisa A. Suen et al. Molecular Cancer Research December 2019.
• ETV4 Is Necessary for Estrogen Signaling and Growth in Endometrial Cancer Cells
  Adriana C. Rodriguez et al. Cancer Research March 2020.